EXOZ logo

EXOZ eXoZymes, Inc.

NASDAQ Global Market · Biotechnology · Healthcare

$3.40
-0.03 (-0.87%)

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Market Cap: $32.10Mexozymes.com

Price

No data yet.

Social Signal Score

50
5d
—
30d
—
60d
50
2 mentions
—
90d
50
3 mentions
—
news: 3

Revenue

$0.00
$0.00
Dec 2022Sep 2026

Analyst Estimates

FY2026
$-1.19
$-1.19–$-1.19
1 analysts
FY2027
$-1.12
$-1.12–$-1.12
1 analysts
FY2028
$-0.47
$-0.47–$-0.47
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Michael Heltzen
Sector
Healthcare
Industry
Biotechnology
Employees
32
Beta
3.35
Country
US
Piotroski score
1 / 9 (Weak)
Altman Z-score
-7.41
exozymes.com